Literature DB >> 27564248

Determination of antibacterial agent tilmicosin in pig plasma by LC/MS/MS and its application to pharmacokinetics.

Bing Li1,2,3, Shi-Yue Gong4, Xu-Zheng Zhou1,2,3, Ya-Jun Yang1,2,3, Jian-Yong Li1,2,3, Xiao-Juan Wei1,2,3, Fu-Sheng Cheng1,2,3, Jian-Rong Niu1,2,3, Xi-Wang Liu1,2,3, Ji-Yu Zhang1,2,3.   

Abstract

A rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated to quantify tilmicosin in pig plasma. Plasma samples were prepared by liquid-liquid extraction. Chromatographic separation was achieved on a C18 column (2.1 × 30 mm, 3.5 μm) using acetonitrile-water (90:10, v/v; water included 0.1% formic acid) as the mobile phase. Mass detection was carried out using positive electrospray ionization in multiple reaction monitoring mode. The calibration curve was linear from 0.5 to 2000 ng/mL (r2  = 0.9998). The intra- and inter-day accuracy and precision were within the acceptable limits of ±10% for all tilmicosin concentrations. The recoveries ranged from 95 to 99% for the three tested concentrations. The LC-MS/MS method described herein was simple, fast and less laborious than other methods, achieved high sensitivity using a small sample volume, and was successfully applied to pharmacokinetic studies of tilmicosin enteric granules after oral delivery to pigs. In comparison with tilmicosin premix, tilmicosin enteric granules slowed the elimination rate of tilmicosin, prolonged its period of action and significantly improved its bioavailability.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  LC/MS/MS; pharmacokinetics; pig plasma; tilmicosin; tilmicosin enteric granules

Mesh:

Substances:

Year:  2016        PMID: 27564248     DOI: 10.1002/bmc.3825

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  4 in total

1.  Pharmacokinetics and bioequivalence of two imidocarb formulations in cattle after subcutaneous injection.

Authors:  Honglei Wang; Chen Chen; Maolin Liu; Xiaojie Chen; Chunshuang Liu; Yanyan Feng; Xinbo Yan; Yiming Liu; Xiubo Li
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

2.  Determination and pharmacokinetics study of UK-5099 in mouse plasma by LC-MS/MS.

Authors:  Qingyuan Zeng; Hongfei Si; Kun Lv; Jiao Mo; Xinnian Wang; Biqing Yan; Jili Zhang
Journal:  BMC Vet Res       Date:  2022-04-20       Impact factor: 2.792

3.  Synthesis of Tilmicosin Nanostructured Lipid Carriers for Improved Oral Delivery in Broilers: Physiochemical Characterization and Cellular Permeation.

Authors:  Benazir Sahito; Qian Zhang; Haifeng Yang; Lin Peng; Xiuge Gao; Jam Kashif; Zain Ul Aabdin; Shanxiang Jiang; Liping Wang; Dawei Guo
Journal:  Molecules       Date:  2020-01-13       Impact factor: 4.411

4.  Efficacy of enteric-coated tilmicosin granules in pigs artificially infected with Actinobacillus pleuropneumoniae serotype 2.

Authors:  Zhen Dong; Xu-Zheng Zhou; Ji-Chao Sun; Xiao-Bin Meng; Hong-Sheng Li; Fu-Sheng Cheng; Xiao-Juan Wei; Bing Li; Wei-Wei Wang; Ji-Yu Zhang
Journal:  Vet Med Sci       Date:  2019-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.